Outcome of Transcatheter Aortic Valve Implantation in Patients with Peripheral Vascular Disease

Fahed Darmoch, M. Chadi Alraies, Yasser Al-khadra, Homam Moussa Pacha, Mohamad Soud, Amir Kaki, Tanveer Rab, Cindy L. Grines, Rodrigo Bagur, Chun Shing Kwok, Mamas Mamas, Subhash Banerjee, Wael AlJaroudi, Duane S. Pinto

Research output: Contribution to journalArticle

Abstract

Peripheral vascular disease (PVD)is common in patients referred for transcatheter aortic valve implantation (TAVI). We sought to investigate the impact of PVD on patients who underwent TAVI. Using data from the National Inpatient Sample database 2011 and 2014, we identified patients who had undergone TAVI. We studied the clinical characteristics and procedural outcomes in patients with PVD who underwent TAVI compared with those patients without PVD using propensity score matching score matching. Results: A total of 42,215 patients underwent TAVI; of which 1,388 patients were matched using propensity score matched scores to 694 in each (PVD vs no PVD)patients. The population had a mean age of 81 years old and 55.8% were of female gender. African-Americans constituted 4.3%. PVD patients who underwent TAVI were found to have higher rates of vascular complications (11.8% vs 5.9 % p <0.001)compared with non-PVD patients and tended to have higher mortality (5.5% vs 3.6%, p = 0.121)and post-TAVI bleeding (13.5% vs 12% p = 0.143). In conclusion, PVD patients have higher in-hospital mortality and higher incidence of in-hospital overall complications compared with patients who have no PVD.

Original languageEnglish (US)
JournalAmerican Journal of Cardiology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Peripheral Vascular Diseases
Propensity Score
Transcatheter Aortic Valve Replacement
Hospital Mortality
Vascular Diseases
African Americans
Blood Vessels
Inpatients
Databases

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Outcome of Transcatheter Aortic Valve Implantation in Patients with Peripheral Vascular Disease. / Darmoch, Fahed; Alraies, M. Chadi; Al-khadra, Yasser; Pacha, Homam Moussa; Soud, Mohamad; Kaki, Amir; Rab, Tanveer; Grines, Cindy L.; Bagur, Rodrigo; Kwok, Chun Shing; Mamas, Mamas; Banerjee, Subhash; AlJaroudi, Wael; Pinto, Duane S.

In: American Journal of Cardiology, 01.01.2019.

Research output: Contribution to journalArticle

Darmoch, F, Alraies, MC, Al-khadra, Y, Pacha, HM, Soud, M, Kaki, A, Rab, T, Grines, CL, Bagur, R, Kwok, CS, Mamas, M, Banerjee, S, AlJaroudi, W & Pinto, DS 2019, 'Outcome of Transcatheter Aortic Valve Implantation in Patients with Peripheral Vascular Disease', American Journal of Cardiology. https://doi.org/10.1016/j.amjcard.2019.04.047
Darmoch, Fahed ; Alraies, M. Chadi ; Al-khadra, Yasser ; Pacha, Homam Moussa ; Soud, Mohamad ; Kaki, Amir ; Rab, Tanveer ; Grines, Cindy L. ; Bagur, Rodrigo ; Kwok, Chun Shing ; Mamas, Mamas ; Banerjee, Subhash ; AlJaroudi, Wael ; Pinto, Duane S. / Outcome of Transcatheter Aortic Valve Implantation in Patients with Peripheral Vascular Disease. In: American Journal of Cardiology. 2019.
@article{e7111d3ae514464cae64f287c4e2c084,
title = "Outcome of Transcatheter Aortic Valve Implantation in Patients with Peripheral Vascular Disease",
abstract = "Peripheral vascular disease (PVD)is common in patients referred for transcatheter aortic valve implantation (TAVI). We sought to investigate the impact of PVD on patients who underwent TAVI. Using data from the National Inpatient Sample database 2011 and 2014, we identified patients who had undergone TAVI. We studied the clinical characteristics and procedural outcomes in patients with PVD who underwent TAVI compared with those patients without PVD using propensity score matching score matching. Results: A total of 42,215 patients underwent TAVI; of which 1,388 patients were matched using propensity score matched scores to 694 in each (PVD vs no PVD)patients. The population had a mean age of 81 years old and 55.8{\%} were of female gender. African-Americans constituted 4.3{\%}. PVD patients who underwent TAVI were found to have higher rates of vascular complications (11.8{\%} vs 5.9 {\%} p <0.001)compared with non-PVD patients and tended to have higher mortality (5.5{\%} vs 3.6{\%}, p = 0.121)and post-TAVI bleeding (13.5{\%} vs 12{\%} p = 0.143). In conclusion, PVD patients have higher in-hospital mortality and higher incidence of in-hospital overall complications compared with patients who have no PVD.",
author = "Fahed Darmoch and Alraies, {M. Chadi} and Yasser Al-khadra and Pacha, {Homam Moussa} and Mohamad Soud and Amir Kaki and Tanveer Rab and Grines, {Cindy L.} and Rodrigo Bagur and Kwok, {Chun Shing} and Mamas Mamas and Subhash Banerjee and Wael AlJaroudi and Pinto, {Duane S.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.amjcard.2019.04.047",
language = "English (US)",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Outcome of Transcatheter Aortic Valve Implantation in Patients with Peripheral Vascular Disease

AU - Darmoch, Fahed

AU - Alraies, M. Chadi

AU - Al-khadra, Yasser

AU - Pacha, Homam Moussa

AU - Soud, Mohamad

AU - Kaki, Amir

AU - Rab, Tanveer

AU - Grines, Cindy L.

AU - Bagur, Rodrigo

AU - Kwok, Chun Shing

AU - Mamas, Mamas

AU - Banerjee, Subhash

AU - AlJaroudi, Wael

AU - Pinto, Duane S.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Peripheral vascular disease (PVD)is common in patients referred for transcatheter aortic valve implantation (TAVI). We sought to investigate the impact of PVD on patients who underwent TAVI. Using data from the National Inpatient Sample database 2011 and 2014, we identified patients who had undergone TAVI. We studied the clinical characteristics and procedural outcomes in patients with PVD who underwent TAVI compared with those patients without PVD using propensity score matching score matching. Results: A total of 42,215 patients underwent TAVI; of which 1,388 patients were matched using propensity score matched scores to 694 in each (PVD vs no PVD)patients. The population had a mean age of 81 years old and 55.8% were of female gender. African-Americans constituted 4.3%. PVD patients who underwent TAVI were found to have higher rates of vascular complications (11.8% vs 5.9 % p <0.001)compared with non-PVD patients and tended to have higher mortality (5.5% vs 3.6%, p = 0.121)and post-TAVI bleeding (13.5% vs 12% p = 0.143). In conclusion, PVD patients have higher in-hospital mortality and higher incidence of in-hospital overall complications compared with patients who have no PVD.

AB - Peripheral vascular disease (PVD)is common in patients referred for transcatheter aortic valve implantation (TAVI). We sought to investigate the impact of PVD on patients who underwent TAVI. Using data from the National Inpatient Sample database 2011 and 2014, we identified patients who had undergone TAVI. We studied the clinical characteristics and procedural outcomes in patients with PVD who underwent TAVI compared with those patients without PVD using propensity score matching score matching. Results: A total of 42,215 patients underwent TAVI; of which 1,388 patients were matched using propensity score matched scores to 694 in each (PVD vs no PVD)patients. The population had a mean age of 81 years old and 55.8% were of female gender. African-Americans constituted 4.3%. PVD patients who underwent TAVI were found to have higher rates of vascular complications (11.8% vs 5.9 % p <0.001)compared with non-PVD patients and tended to have higher mortality (5.5% vs 3.6%, p = 0.121)and post-TAVI bleeding (13.5% vs 12% p = 0.143). In conclusion, PVD patients have higher in-hospital mortality and higher incidence of in-hospital overall complications compared with patients who have no PVD.

UR - http://www.scopus.com/inward/record.url?scp=85066500686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066500686&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2019.04.047

DO - 10.1016/j.amjcard.2019.04.047

M3 - Article

C2 - 31174835

AN - SCOPUS:85066500686

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

ER -